# Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

> **NCT00361283** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 108 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00361283
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2008-12
- **Final completion:** 2009-01
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2012-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361283, "Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00361283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*